A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

With weight loss drugs like Ozempic and Mounjaro becoming widespread, it can be tempting to look for a quick fix. Official stats on how many Brits are using semaglutides, which mimic the action of the ...

With weight loss drugs like Ozempic and Mounjaro becoming widespread, it can be tempting to look for a quick fix. Official stats on how many Brits are using semaglutides, which mimic the action of ...

Fresh questions are being asked about the use of weight loss ... its stronger dose form, branded as Wegovy, could help users lose 15% of their body weight in 68 weeks. Ozempic is only prescribed ...

Bloomberg/Getty Images One big area of concern for users of GLP-1 medications such as Ozempic and Wegovy is preventing muscle loss during weight loss. Salk Institute researchers have identified ...